胃癌患者报告结局量表的研制与计量心理学特征考核

详细信息    查看全文 | 推荐本文 |

英文篇名：Development and Psychometric Evaluation of Patient-reported Outcomes Scale for Gastric Cancer 作者：刘佳文 ; 赵芬 ; 张艳娜 ; 刘近春 ; 张岩波 英文作者：Liu Jiawen;Zhao Fen;Zhang Yanna;Department of Health Statistics,Shanxi Medical University; 关键词：胃癌 ; 生存质量评价 ; 信度 ; 效度 ; 患者报告结局 英文关键词：Gastric cancer;;Evaluation of quality of life;;Reliability;;Validity;;Patient-report outcome 中文刊名：ZGWT 英文刊名：Chinese Journal of Health Statistics 机构：山西医科大学统计教研室;山西医科大学第一临床医学院; 出版日期：2019-06-25 出版单位：中国卫生统计 年：2019 期：v.36 基金：国家自然科学基金(81872714) 语种：中文; 页：ZGWT201903003 页数：4 CN：03 ISSN：21-1153/R 分类号：12-15

摘要

目的基于PRO在测量疾病负担和评价临床疗效中的特点,本研究旨在开发特异性胃癌患者PRO量表,并对量表的计量心理学特征进行考核。方法使用经典测量理论和项目反应理论,经条目筛选制定出胃癌PRO量表,再进行信度、效度和可行性考核。结果胃癌PRO量表包含38个条目,生理领域、心理领域、社会领域和治疗领域的克朗巴赫α系数分别为:0.880、0.890、0.751和0.859,总量表为0.926;验证性因子分析显示该量表具有较好的结构效度,回收率和有效率均高于90%。结论 GC-PRO量表具有较高的信度、效度和可行性。
        Objective Based on the characteristics and functions of PRO in measuring disease burden and evaluating clinical efficacy,a specific PRO measure of gastric cancer was developed.And the psychometric properties of it was assessed.Methods The items were selected by the method of classical test theory and item response theory.And after the recovery of the questionnaire,these scale was evaluated by reliability,validity and feasibility.Results The final GC-PRO scale contained 38 items.The Cronbach's alpha coefficients in the physiological,psychological,social,therapeutic domains,and total scale were 0.880,0.890,0.751,0.859,and 0.926,respectively.The results of confirmatory factor analysis showed that the scale had a good construct validity.The recovery rate and the effective rate were higher than 90%.And it took about 15 minutes to fill in the scale.Conclusion The GC-PRO scale had high reliability,validity,and acceptability.

引文

[1]CHEN X Z,LIU Y,WANG R,et al.Improvement of cancer control in mainland China:epidemiological profiles during the 2004-10 National Cancer Prevention and Control Program.Lancet,2016,388(S40-S.
    [2]BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality w orldw ide for 36 cancers in 185 countries.CA:A Cancer Journal for Clinicians,2018,68(6):394-424.
    [3]LI L.Chinese Society of Clinical Oncology(CSCO)establishes an Antitumor PDT Expert Committee.Photodiagnosis&Photodynamic Therapy,2011,8(4):348.
    [4]FDA.Guidance for industry:patient-reported outcome measures:use in medical product development to support labeling claims:draft guidance.Health and Quality of Life Outcomes,4,1(2006-10-11),2006,4(1):79-.
    [5]DENNISTON A K,KYTE D,.,CALVERT M,.,et al.An introduction to patient-reported outcome measures in ophthalmic research.Eye,2014,28(6):637.
    [6]郑君,郑坚,郑培永.生存质量量表在胃癌疗效评价中的应用进展.中西医结合学报,2008,03):304-10.
    [7]周丐晓,刘恩山.整合CTT和IRT技术提高监测工具质量---以小学科学试卷为例.首都师范大学学报(自然科学版),2018,39(04):54-61.
    [8]张岩波.潜变量分析[M].北京:高等教育出版社,2009:94-98
    [9]吴化宇,丁婕,雒朝君.基于验证性因子分析的中医工作满意度量表研制.中国卫生统计,2019,01):92-5.
    [10]王宁,刘硕,杨雷.2018全球癌症统计报告解读.肿瘤综合治疗电子杂志,2019,5(01):87-97.